Coronary artery disease in women

Indian Heart Journal

Volumn 53, Issue 3, 2001, Pages 282-292

  Enas, Enas A ^a   Senthilkumar, A ^b   Juturu, Vijaya ^b   Gupta, Rajeev ^b  

^a Coronary Artery Dis in Indians Res ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; INDIA; MALE; REVIEW; RISK FACTOR;

CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; INDIA; MALE; RISK FACTORS;

EID: 0035349258     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Mark DB. Sex bias in cardiovascular care: Should women be treated more like men? JAMA 2000; 283: 659-661
2. Wenger NK. Coronary artery disease in older women: prevention, diagnosis, management, and prognosis. Clin Geriatr 1995; 3: 41-47
3. Sheth T, Yusuf S. Contrasting rates of heart disease and lung cancer among South Asians, Chinese, and European Canadians examined in an international context. CVD Prevention 1998; 1: 19-24
4. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596-601
5. Gupta R. Coronary heart disease epidemiology in India: the past, present and future. In: Rao GHR (ed). Coronary Artery Disease in South Asians. New Delhi: Jaypee: 2001. pp. 6-28
6. Wu Z, Yao C, Zhao D, Wu G, Wang W, Liu J, et al. Sino-MONICA Project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part 1: Morbidity and mortality monitoring. Circulation 2001; 103: 462-468
7. Wild SH, Laws A, Fortmann SP, Varady AN, Byrne CD. Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985-1990. Ann Epidemiol 1995; 5: 432-439
8. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJ. Failure of women's hearts. Circulation 1999; 99: 2334-2341
9. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995; 155: 57-61
10. Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991: presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996; 93: 1981-1992
11. Barakat K, Wilkinson P, Suliman A, Ranjadayalan K, Timmis A. Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am Heart J 2000; 140: 740-746
12. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001; 134: 173-181
13. Kannel WB. Bishop lecture. Contribution of the Framingham Study to preventive cardiology. J Am Coll Cardiol 1990; 15: 206-211
14. Milner KA, Funk M, Richards S, Wilmes RM, Vaccarino V, Krumholz HM. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol 1999; 84: 396-399
15. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation 1993; 88: 1999-2009
16. Sharma SN, Kaul U, Wasir HS, Manchanda SC, Bahl VK, Talwar KK, et al. Coronary arteriographic profile in young and old Indian patients with ischaemic heart disease: A comparative study. Indian Heart J 1990; 42: 365-369
17. Gupta R, Puri V, Narain V. Cardiovascular risk profile in Indian women(Abstr). Indian Heart J 1999; 51: 679
18. Reddy KS, Shah P, Prabhakaran P, Shah B, Prabhakar A, Shrivastava U, et al. Coronary heart disease risk factors in an industrial population in North India (Abstr). Indian Heart J 1997; 49: 659
19. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 2000; 84: 238-244
20. Forouhi N, McKeigue P. How far can risk factors account for excess coronary mortality in South Asians? Can J Cardiol 1997; 13(Suppl B): 47B
21. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five year follow-up of the seven countries study. JAMA 1995; 274: 131-136
22. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-284
23. Beverly RK, Siscovick D, Schwartz S, Koepsell T, Psaty B, Longstreth W. Family history and risk of myocardial infarction in young women. Circulation 1996; 93: 635
24. Kornowski R, Lansky AJ, Mintz GS, Kent KM, Pichard AD, Satler LF, et al. Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol 1997; 79: 1601-1605
25. Palmer JR, Rosenberg L, Shapiro S. Stature and the risk of myocardial infarction in women. Am J Epidemiol 1990; 132: 27-32
26. NHLBI Obesity Task Force. Clinical guideline on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obese Res 1998; 6 (Suppl 2): 51S-209S
27. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685
28. Redefining obesity and its treatment - the Asia-Pacific perspective 2000: International Diabetes Institute in Australia and WHO. www.diabetes.com.au/research/report_obesity.htm Accessed 6 June, 2001
29. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-1848
30. Prabhakaran D, Shah P, Joshi M, Puri S, Reddy K. Generalized obesity is also an important coronary heart disease risk factor in Indians (Abstr). Indian Heart J 1997; 49: 619
31. Snell PG, Mitchell JH. Physical inactivity: an easily modified risk factor? Circulation 1999; 100: 2-4
32. Whitty CJ, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study. Atherosclerosis 1999; 142: 279-286
33. Yuan JM, Ross RK, Wanh XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai. China: a prospective male cohort study. JAMA 1996; 275: 1646-1650
34. Huang Z, Willett WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998; 128: 81-88
35. Stern MP. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia 1994; 37: 956-958
36. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
37. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease In women than in men? The Rancho Bernardo Study. JAMA 1991; 265: 627-631
38. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998; 158: 617-621
39. Newnham HH, Silberberg J. Coronary heart disease. Women's hearts are hard to break. Lancet 1997; 349:S13-S16
40. O'Keefe JH, Miles JM, Harris WH, Moe RM, McCallister BD. Improving the adverse cardiovascular prognosis of Type 2 diabetes. Mayo Clin Proc 1999; 74: 171-180
41. Kitching AD, Yusuf S. From journal to bedside: quantifying the benefits of treatment. Evidence Based Cardiovascular Medicine 1997: 57-58
42. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA 1993; 269: 3002-3008
43. Enas EA. Coronary artery epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc 2000; 98: 694-702
44. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-949
45. Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening and myocardial infarction.The Framingham Study. Arteriosclerosis 1988; 8: 207-211
46. Reddy KS, Prabhakaran D, Shah P, Prabhakar A, Shah B, Bahl V, et al. Estimation of cholesterol alone may fail to identify majority of high risk subjects for coronary heart disease (Abstr). Indian Heart J 1997; 49: 597
47. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein levels: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-219
48. Bengtsson C, Bjorkelund C, Lapidus L, Lissner L. Associations of serum lipid concentrations and obesity with mortality in women: 20-year follow-up of participants in prospective population study in Gothenburg, Sweden. BMJ 1993; 307: 1385-1388
49. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Low triglycerides, high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 2001; 161: 361-366
50. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993; 88: 381-387
51. Enas EA. Triglycerides and small, dense low-density lipoprotein. JAMA 1998; 280: 1990-1991
52. Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000; 23: 1679-1685
53. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75
54. Bahl VK, Vaswani M, Thatai D, Wasir HS. Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease. Int J Cardiol 1994; 46: 143-149
55. Hopkins PN, Wu L, Hunt S, James BC, Vincent GM, Williams RR. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 2783-2792
56. Berg K, Dahlen G, Christophersen B, Cook T, Kjekshus J, Pedersen T. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study. Clin Genet 1997; 52: 254-261
57. Enas EA. Why is there an epidemic of malignant CAD in young Indians? Asian J Clin Cardiol 1998; 1: 43-59
58. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057
59. Hughes K, Ong CN. Vitamins, selenium, iron and coronary heart disease risk in Indians, Malays and Chinese In Singapore. J Epidemiol Community Health 1998; 52: 181-185
60. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83: 660-666
61. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol 1996; 28: 1214-1219
62. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study). Am J Cardiol 2001; 87: 937-941
63. Fisher LD, Kennedy JW, Chaitman BR, Ryan TJ, McCabe C, Weiner D, et al. Diagnostic quantification of CASS (Coronary Artery Surgery Study) clinical and exercise test results in determining presence and extent of coronary artery disease: A multivariate approach. Circulation 1981; 63: 987-1000
64. Kuhn FE, Rackley CE. Coronary artery disease in women. Risk factors, evaluation, treatment and prevention. Arch Intern Med 1993; 153: 2626-2636
65. Malenka DJ, O'Connor GT, Quinton H, Wennberg D, Robb JF, Shubrooks S, et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty: a regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. Circulation 1996; 94: 99-104
66. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women - a statement for healthcare professionals from the American Heart Association. Circulation 1997; 96: 2468-2482
67. Bell MR, Holmes DR Jr, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. JAMA 1993; 269: 2091-2095
68. Roger VL, Farkouh ME, Weston SA, Reeder GS, Jacobsen SJ, Zinsmeister AR, et al. Sex differences in evaluation and outcome of unstable angina. JAMA 2000; 283: 646-652
69. Hannan EL, Bernard HR, Kilburn HC Jr, O'Donnell JF. Gender differences in mortality rates for coronary artery bypass surgery. Am Heart J 1992; 123: 866-872
70. Dodge JT, Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human coronary arteries: Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 1992; 86: 232-246
71. O'Connor NJ, Morton JR, Birkmeyer JD, Olmstead EM, O'Connor GT. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1996; 93: 652-655
72. Sprecher DL, Pearce GL, Park EM, Pashkow FJ, Hoogwerf BJ. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: A sex analysis. Diabetes Care 2000; 23: 1648-1653
73. POSTCABG. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997; 336: 153-162
74. Jacobs AK, Kelsey SF, Brooks MM, Faxon DP, Chaitman BR, Bittner V, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1998; 98: 1279-1285
75. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332: 1758-1766
76. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000; 102: 2284-2299
77. Mosca L, Grundy SM, Judelson D, King K, Limacher M, Oparil S, et al. Guide to Preventive Cardiology for Women: AHA/ACC Scientific Statement Consensus Panel Statement. Circulation 1999; 99: 2480-2484
78. Schrot HG, Bittner BV, Vittingorf E, Herrington DM, Hulley S. Adherence to NCEP treatment goals in postmenopausal women with heart disease: Heart and Estrogen/Progestin Replacement Study (HERS). JAMA 1997; 277: 1281-1286
79. Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol And Recurrent Events (CARE) trial. J Am Coll Cardiol 1998; 32: 140-146
80. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
81. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357
82. Downs JR, Clearfield M, Weiss S, Whitney E, Shapiro D, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279: 1615-1622
83. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999; 282: 2340-2346
84. Falk E. Stable versus unstable atherosclerosis: clinical aspects. Am Heart J 1999; 138: S421-S425
85. Davies MJ. The vulnerable plaque. N Engl J Med 1997; 336: 1312-1314
86. Edwards CJ, Hart DJ, Spector TD. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 2000; 355: 2218-2219
87. Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM, et al. Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) project. Circulation 2001; 103: 387-392
88. Grover S. Gambling with cardiovascular risk: picking the winners and the losers. Lancet 1999; 353: 254-255
89. Davidson NE. Hormone-replacement therapy - breast versus heart versus bone. N Engl J Med 1995; 332: 1638-1639
90. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-612
91. Simon J, Hsia J, Cauley JA, Richards C, Harris F, Fong J, et al. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 2001; 103: 638-642
92. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, et al. Fffects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000; 343: 522-529
93. Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 2000; 283: 1845-1852
94. Kamath SK, Hussain EA, Amin D, Mortillaro E, West B, Peterson CT, et al. Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women. Am J Clin Nutr 1999; 69: 621-631
95. Sheth T, Nair C, Nargundkar M, Anand S, Yusul S. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. Can Med J 1999; 161: 132-138
96. Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991; 325: 226-230
97. Enas EA. High rates of CAD in Asian Indians in the United States despite intense modification of lifestyle: What next? Curr Science 1998; 74: 1081-1086
98. Pearson TA, Myerson M. Treatment of hypercholesterolemia in women - equality, effectiveness, and extrapolation of evidence. JAMA 1997; 277: 1320-1321